SYN-AKE, a synthetic tripeptide (Dipeptide Diaminobutyroyl), represents a compelling research tool for investigating dermal neuromuscular-signaling mechanisms, with its characterization and purity being paramount for reliable scientific exploration. Robust quality control and meticulous analytical testing are critical for ensuring the integrity of in vitro and in vivo research outcomes.
As a compound with numerous publications indexed in PubMed and several registered studies on ClinicalTrials.gov (though exclusively for investigational purposes, never as an approved therapeutic), SYN-AKE’s consistent chemical identity and high purity are foundational for mechanistic studies and comparative analyses. Researchers employing SYN-AKE must thoroughly understand the methodologies used to verify its composition, stereochemistry, and absence of significant impurities, thereby enabling accurate interpretation of its observed biological effects in controlled experimental settings.
Introduction to SYN-AKE in Cellular Aging Research Context
SYN-AKE, classified as a synthetic tripeptide, has garnered significant attention in various fields of biological research, particularly for its unique mechanism of action mimicking the activity of the Temple Viper venom peptide. Specifically, it is a synthetic tripeptide studied extensively in dermal neuromuscular-signaling research. While its initial focus has been on understanding neuromuscular signal modulation in skin biology, its broader implications for cellular signaling pathways make it a compelling subject for cellular aging research. The complex interplay of signal transduction, protein function, and cellular resilience are central to aging processes, and compounds like SYN-AKE, which modulate specific aspects of cellular communication, serve as invaluable probes for mechanistic studies. Research into SYN-AKE’s interactions with cellular receptors, ion channels, or downstream effectors can shed light on fundamental processes that govern cell longevity, stress response, and tissue homeostasis, all critical elements in the etiology of cellular aging.
The utility of SYN-AKE in cellular aging research extends beyond its immediate known mechanism. As a well-characterized synthetic peptide, it provides a controlled tool for investigating how specific signaling perturbations might influence age-related cellular phenotypes. For instance, researchers might explore its impact on mitochondrial function, telomere dynamics, senescence-associated secretory phenotype (SASP), or autophagy pathways in various cell types relevant to aging, such as fibroblasts, keratinocytes, or even neuronal cells, given its neuromuscular research context. With numerous PubMed publications indexed and several ClinicalTrials.gov registered studies providing a foundation of knowledge regarding its properties and biological activity, SYN-AKE offers a robust starting point for deeper inquiries into its potential roles as a modulator of cellular aging processes. Understanding its precise molecular interactions in diverse cellular contexts is paramount for advancing our knowledge in this complex field. More information on the ongoing research involving this fascinating compound can be found on our dedicated SYN-AKE research page.
However, the reliability and reproducibility of such intricate cellular aging studies are profoundly dependent on the quality and purity of the research materials employed. The introduction of impurities or inconsistent material can lead to erroneous data, misinterpretations of results, and a significant impediment to scientific progress. Therefore, rigorous characterization and stringent purity assessment of SYN-AKE are not merely good laboratory practice but are foundational requirements for any meaningful investigation into its cellular effects, especially within the sensitive and multifactorial domain of cellular aging research. This document aims to detail the comprehensive testing protocols employed to ensure the highest standard of SYN-AKE purity for research applications, thereby supporting robust and reliable scientific discovery.
Chemical Structure, Synthesis Pathways, and Potential Impurities of SYN-AKE
SYN-AKE is known by the alias Dipeptide Diaminobutyroyl, reflecting its core chemical composition as a tripeptide. Peptides are short chains of amino acid monomers linked by peptide bonds, and their precise primary, secondary, and tertiary structures dictate their biological activity. As a synthetic tripeptide, SYN-AKE’s structure is carefully designed to elicit a specific biological response. The synthesis of such complex biomolecules typically relies on highly controlled chemical reactions to ensure the correct sequence and stereochemistry. The most common method for peptide synthesis is Solid-Phase Peptide Synthesis (SPPS), pioneered by R.B. Merrifield. SPPS involves the stepwise addition of protected amino acid derivatives to a growing peptide chain anchored to an insoluble polymeric resin. Each amino acid addition requires a cycle of deprotection, coupling, and washing, followed by subsequent removal of the peptide from the resin and purification.
While SPPS is highly efficient, the repetitive nature of the synthesis steps makes it susceptible to various side reactions and incomplete transformations, leading to a spectrum of potential impurities. The quality of raw materials, reaction conditions, and purification protocols significantly influence the final product’s purity. Key categories of impurities frequently encountered in synthetic peptides like SYN-AKE include:
- Deletion Sequences: Result from incomplete coupling reactions, where one or more amino acids are skipped in the sequence. These are particularly problematic as they are structurally similar to the target peptide.
- Truncated Sequences: Occur when the peptide chain terminates prematurely, either at the N-terminus or C-terminus, often due to premature cleavage from the resin or incomplete deprotection.
- Side-Chain Modifications: Undesired alterations to the amino acid side chains, such as oxidation (e.g., methionine, tryptophan), deamidation (asparagine, glutamine), or alkylation.
- Racemization: The conversion of an amino acid’s natural L-configuration to the D-configuration, which can significantly alter the peptide’s biological activity and recognition by receptors.
- Adducts and Derivatives: Residual protecting groups, counterions, or other reagents from the synthesis and cleavage steps that remain covalently or non-covalently bound to the peptide.
- Aggregates and Oligomers: Peptides, especially longer or more hydrophobic ones, can self-associate to form dimers, trimers, or larger aggregates, particularly during purification or storage.
- Residual Solvents and Heavy Metals: Solvents used during synthesis, cleavage, and purification must be thoroughly removed, and catalysts or reagents can introduce heavy metal contamination.
The presence of any of these impurities, even in trace amounts, can drastically impact the research outcomes when using SYN-AKE. For instance, an impurity with agonist or antagonist activity could confound results, leading to misinterpretation of SYN-AKE’s true mechanism or potency in cellular aging models. Furthermore, impurities can introduce cytotoxicity or alter cellular viability, undermining the validity of experimental controls. Therefore, comprehensive analytical strategies are indispensable to identify and quantify these potential contaminants, ensuring that research-grade SYN-AKE meets stringent purity standards for reliable and reproducible scientific inquiry.
High-Performance Liquid Chromatography (HPLC) for SYN-AKE Purity Assessment
High-Performance Liquid Chromatography (HPLC) stands as a cornerstone analytical technique for the assessment of purity and identification of impurities in synthetic peptides like SYN-AKE. This robust chromatographic method separates components of a mixture based on their differential partitioning between a stationary phase and a mobile phase, driven under high pressure. For peptides, reverse-phase HPLC (RP-HPLC) is the most widely adopted configuration due to its excellent resolution for compounds with varying hydrophobicities. In RP-HPLC, the stationary phase is typically non-polar (e.g., C18 silica), and the mobile phase is a polar solvent mixture (e.g., water/acetonitrile with an acidic modifier like trifluoroacetic acid, TFA). The peptide and its impurities interact differentially with the stationary phase, leading to their separation as they elute from the column at distinct retention times.
The utility of HPLC for SYN-AKE purity assessment is multifaceted. It provides a highly sensitive and quantitative measure of the primary peptide’s concentration relative to any co-eluting impurities. Detection is commonly achieved using ultraviolet (UV) absorbance at specific wavelengths (e.g., 214 nm for peptide bonds), often coupled with a Diode Array Detector (DAD) to provide spectral information, aiding in impurity identification. A typical HPLC chromatogram for SYN-AKE would display a prominent peak corresponding to the target tripeptide, with any additional peaks indicating the presence of related substances or impurities. The purity is generally calculated as the area percentage of the main peak relative to the total area of all detected peaks, excluding solvent and buffer peaks. Ensuring batch-to-batch consistency in SYN-AKE purity requires strict adherence to validated HPLC methods.
To achieve optimal separation and quantification of SYN-AKE and its potential impurities, several critical parameters must be meticulously controlled in HPLC:
| Parameter | Importance for SYN-AKE Purity |
|---|---|
| Column Chemistry | Typically C18 or C8 for peptides. Particle size and pore size influence resolution. Must be consistent between runs. |
| Mobile Phase Composition | A gradient of increasing organic solvent (e.g., acetonitrile) in an aqueous buffer (e.g., 0.1% TFA) is crucial for separating peptides based on hydrophobicity. pH control is vital. |
| Flow Rate & Temperature | Maintain constant conditions to ensure reproducible retention times and peak shapes. Temperature control enhances separation efficiency. |
| Detection Wavelength | 214 nm is standard for peptide backbone, but other wavelengths (e.g., 280 nm for aromatic amino acids) can provide additional information for specific impurities. |
| Injection Volume & Concentration | Appropriate loading ensures detector linearity and prevents column overloading, which can distort peak shapes and accuracy. |
While HPLC provides an excellent initial assessment of purity, it is often complemented by other techniques, such as Mass Spectrometry, for definitive identification of impurities and structural elucidation. However, for routine quality control and ensuring that each batch of SYN-AKE supplied for research purposes meets a specified minimum purity threshold (e.g., >98%), HPLC is indispensable. It offers a fast, reliable, and quantifiable metric of peptide integrity, directly contributing to the reproducibility and trustworthiness of cellular aging research employing SYN-AKE. Such rigorous quality testing is a non-negotiable aspect of supplying high-grade research materials.
Mass Spectrometry (MS) Techniques for Comprehensive SYN-AKE Characterization
Mass Spectrometry (MS) stands as an indispensable analytical tool in the comprehensive characterization and purity assessment of research-grade peptides like SYN-AKE. Its ability to determine molecular weight with high precision, elucidate structural details through fragmentation, and identify impurities makes it foundational for ensuring the quality of materials used in cellular aging research. For a synthetic tripeptide like SYN-AKE, with its specific dermal neuromuscular-signaling research applications, accurate characterization by MS is paramount for experimental reproducibility and reliable mechanistic investigations.
The initial application of MS involves verifying the intact molecular weight of SYN-AKE, which is critical for confirming its identity as a tripeptide with the alias Dipeptide Diaminobutyroyl. Techniques such as Electrospray Ionization Mass Spectrometry (ESI-MS) or Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry (MALDI-TOF MS) are routinely employed for this purpose. These methods provide high-resolution mass spectra, allowing researchers to accurately determine the monoisotopic or average mass of the peptide and compare it against the theoretical molecular weight. Any significant deviation can signal issues such as incorrect synthesis, oxidative modification, or the presence of adducts, necessitating further investigation.
Beyond simple molecular weight determination, tandem mass spectrometry (MS/MS) techniques, often coupled with liquid chromatography (LC-MS/MS), provide detailed structural information crucial for verifying the amino acid sequence of SYN-AKE. In LC-MS/MS, the peptide is first separated chromatographically from potential impurities before being introduced into the mass spectrometer. Upon collision-induced dissociation (CID) or other fragmentation methods, the peptide breaks into characteristic ‘b’ and ‘y’ ions, which provide a “fingerprint” of the amino acid sequence. This step is vital for confirming the precise connectivity of the amino acids and identifying any sequence variants or truncation products that might compromise the research integrity of the peptide material.
Furthermore, MS is invaluable for impurity profiling and quantification. High-resolution mass spectrometry (HRMS) offers the sensitivity and accuracy required to detect and identify trace impurities that might co-elute with SYN-AKE or have similar physicochemical properties. This capability is critical for understanding the potential impact of synthesis byproducts, partially hydrolyzed peptides, or non-peptide contaminants on cellular responses in research models. Integrating various MS approaches ensures a robust quality testing framework for research-grade SYN-AKE.
Key MS Techniques for SYN-AKE Characterization:
- ESI-MS / MALDI-TOF MS: Intact molecular weight verification, initial identity confirmation.
- LC-MS/MS: Peptide sequence verification through fragmentation patterns (b- and y-ions), identification of post-translational modifications, and chromatographic separation of impurities.
- HRMS (e.g., Q-TOF, Orbitrap): High-resolution and mass accuracy for precise impurity identification and elemental composition determination of unknown species.
- GC-MS: Used for the detection and quantification of volatile organic impurities or residual solvents, complementing peptide-focused MS methods.
Nuclear Magnetic Resonance (NMR) Spectroscopy in SYN-AKE Structural Elucidation and Purity Analysis
Nuclear Magnetic Resonance (NMR) spectroscopy serves as a powerful and non-destructive technique for the unequivocal structural elucidation and purity assessment of research-grade compounds, including complex peptides like SYN-AKE. Unlike mass spectrometry, which primarily provides mass-to-charge information and fragmentation data, NMR offers detailed insights into the spatial arrangement of atoms, their connectivity, and the dynamic behavior of molecules in solution. For SYN-AKE, a synthetic tripeptide, NMR is crucial for confirming the precise chemical structure, stereochemistry, and conformational integrity, which are all vital factors influencing its interaction profile in in vitro and in vivo research models.
The foundation of NMR analysis for peptides begins with one-dimensional (1D) spectra, specifically proton (1H) and carbon-13 (13C) NMR. 1H NMR provides a unique “fingerprint” of the peptide, with each distinct proton environment giving rise to specific chemical shifts and coupling patterns. These data allow researchers to identify different types of protons within the amino acid residues of SYN-AKE, such as alpha-protons, side-chain protons, and amide protons. 13C NMR, though less sensitive, provides complementary information about the carbon backbone and carbonyl carbons, confirming the presence of characteristic peptide bond resonances and specific amino acid carbon environments. Purity can also be assessed by the presence or absence of extraneous signals from non-peptide impurities or residual solvents.
For a detailed and unambiguous assignment of the SYN-AKE structure, two-dimensional (2D) NMR experiments are indispensable. These techniques correlate signals from different nuclei, revealing through-bond and through-space connectivities. Common 2D NMR experiments utilized for peptide characterization include:
Advanced NMR Techniques for SYN-AKE:
- COSY (Correlation Spectroscopy): Identifies protons that are coupled to each other through two or three bonds, establishing spin systems for individual amino acids.
- TOCSY (Total Correlation Spectroscopy): Reveals all protons within a spin system, providing comprehensive mapping of protons within each amino acid residue.
- HSQC (Heteronuclear Single Quantum Coherence) / HMQC (Heteronuclear Multiple Quantum Coherence): Correlate directly bonded protons and carbons (1H-13C), essential for assigning specific carbon signals to their corresponding protons.
- HMBC (Heteronuclear Multiple Bond Correlation): Shows correlations between protons and carbons separated by two, three, or even four bonds, crucial for linking amino acid spin systems across peptide bonds and confirming the overall sequence.
- NOESY (Nuclear Overhauser Effect Spectroscopy) / ROESY (Rotating-frame Overhauser Effect Spectroscopy): Reveal protons that are spatially close, even if not directly bonded, providing insights into the three-dimensional conformation and stereochemistry of SYN-AKE.
By combining data from these 1D and 2D NMR experiments, researchers can meticulously confirm the complete primary structure of SYN-AKE, including its amino acid sequence (as Dipeptide Diaminobutyroyl), side-chain integrity, and absence of racemization or epimerization if stereochemistry is critical. NMR also offers a quantitative aspect, allowing for the precise determination of purity by integrating signal areas of the target peptide versus any identified impurities. This level of structural confirmation and purity assessment is paramount for mechanistic studies in cellular aging research, where subtle structural deviations can lead to profoundly different biological outcomes.
Elemental Analysis, Fourier-Transform Infrared (FTIR) Spectroscopy, and UV-Vis for SYN-AKE Verification
While Mass Spectrometry and NMR spectroscopy provide extensive structural and purity data for research-grade SYN-AKE, a suite of complementary analytical techniques—Elemental Analysis, Fourier-Transform Infrared (FTIR) Spectroscopy, and Ultraviolet-Visible (UV-Vis) Spectroscopy—offers crucial confirmatory information regarding identity, composition, and gross purity. These methods provide independent verification points, strengthening the overall quality control framework for peptide materials used in sensitive cellular aging research.
Elemental Analysis for Stoichiometric Confirmation
Elemental Analysis, often referred to as CHNS analysis, determines the precise percentage composition of carbon (C), hydrogen (H), nitrogen (N), and sulfur (S) in a purified sample of SYN-AKE. By comparing the experimentally determined elemental percentages against the theoretically calculated values for the known chemical formula of the tripeptide, researchers can verify the stoichiometric integrity of the compound. For SYN-AKE, which is a nitrogen-rich peptide, the N content is particularly important for confirmation. Significant discrepancies between experimental and theoretical values can indicate the presence of inorganic impurities, unreacted starting materials, or incomplete synthesis, all of which could impact research outcomes. This analysis provides a fundamental check on the overall elemental makeup, serving as a basic yet powerful validation of the peptide’s identity and gross purity.
Fourier-Transform Infrared (FTIR) Spectroscopy for Functional Group Verification
FTIR spectroscopy is a rapid and non-destructive technique used to identify the functional groups present within the SYN-AKE molecule. The principle behind FTIR is that different chemical bonds and functional groups absorb infrared radiation at characteristic frequencies, producing a unique vibrational spectrum. For peptides, key characteristic absorption bands include:
| FTIR Absorption Band | Description / Significance for SYN-AKE |
|---|---|
| Amide I (~1630-1680 cm-1) | Primarily C=O stretching of the peptide bond; highly sensitive to secondary structure (though less critical for a tripeptide). |
| Amide II (~1520-1550 cm-1) | N-H bending and C-N stretching of the peptide bond. |
| Amide III (~1230-1300 cm-1) | Complex vibrational mode, also related to peptide backbone. |
| N-H stretch (~3300 cm-1) | Characteristic of amide and primary/secondary amine groups. |
| C-H stretch (~2850-2960 cm-1) | Aliphatic C-H bonds from amino acid side chains. |
By analyzing the presence and relative intensities of these bands, researchers can confirm the formation of peptide bonds and the integrity of the amino acid side chains within SYN-AKE. The FTIR spectrum acts as a molecular “fingerprint,” allowing for direct comparison with a known reference standard or theoretical spectrum, ensuring that the synthesized material matches the expected chemical structure. Deviations in the spectrum can reveal impurities or degradation products, such as carbonyls from oxidation or altered amide bands from hydrolysis.
UV-Vis Spectroscopy for Chromophore Detection and Purity Screening
Ultraviolet-Visible (UV-Vis) spectroscopy measures the absorption of light in the UV and visible regions of the electromagnetic spectrum. While SYN-AKE itself, as a simple tripeptide likely lacking aromatic amino acids like tryptophan or tyrosine, may not exhibit strong characteristic absorbance peaks in the UV region typically used for protein quantification (e.g., 280 nm), UV-Vis can still be valuable. It can be used to screen for UV-active impurities that might be present in the sample, even at low concentrations. If the peptide contains specific chromophores or if a derivative method is employed, UV-Vis can also be used for quantitative analysis. Furthermore, the absence of strong, uncharacteristic UV absorption peaks provides an additional layer of evidence for the purity of the research-grade material, indicating the absence of conjugated systems or colored contaminants that absorb in the visible range. Together, these complementary techniques contribute to a robust Certificate of Analysis (CoA) for SYN-AKE, critical for reproducible research.
Assessment of Residual Solvents, Heavy Metals, and Microbial Contaminants in Research-Grade SYN-AKE
The integrity and reproducibility of research involving synthetic peptides such as SYN-AKE are critically dependent on the absence of specific impurities that could confound experimental outcomes. Beyond the primary peptide sequence and purity, residual solvents, heavy metals, and microbial contaminants represent distinct classes of impurities that require stringent control in research-grade materials. Their presence, even at trace levels, can induce cytotoxic effects, alter cellular signaling pathways, or interfere with biochemical assays, thereby compromising the validity and interpretability of studies in cellular aging or dermal neuromuscular signaling research.
Residual Solvents
Synthetic peptides like SYN-AKE are typically manufactured through solid-phase peptide synthesis (SPPS) or solution-phase methods, processes that inherently utilize a variety of organic solvents for coupling, deprotection, and purification steps. Common solvents include N,N-dimethylformamide (DMF), dichloromethane (DCM), acetonitrile, methanol, ethanol, isopropanol (IPA), acetone, ethyl acetate, and toluene. While rigorous washing and drying protocols are employed, trace amounts of these solvents can remain. Research on SYN-AKE’s influence on delicate biological systems, such as cellular viability or neuronal activity, necessitates the removal of these residues to levels below established safety thresholds. Even non-toxic solvents at higher concentrations can impact experimental parameters like solubility, pH, or cellular uptake. Detection and quantification of residual solvents are primarily achieved through gas chromatography (GC) coupled with detectors such as flame ionization detection (FID) or mass spectrometry (MS), offering high sensitivity and specificity for various solvent classes.
Heavy Metals
Heavy metal contamination in research-grade SYN-AKE can originate from multiple sources, including raw materials (e.g., amino acid precursors, resins), catalysts, reagents, or contact with processing equipment. Elements such as lead (Pb), cadmium (Cd), mercury (Hg), arsenic (As), and others are known to exert potent biological effects, including enzyme inhibition, oxidative stress induction, and DNA damage, which are highly relevant in cellular aging research. These metals can profoundly interfere with the physiological responses of cells and tissues used in *in vitro* or *ex vivo* models, leading to spurious results or misinterpretations of SYN-AKE’s intrinsic activity. Robust analytical techniques are crucial for their detection. Inductively Coupled Plasma – Mass Spectrometry (ICP-MS) and Atomic Absorption Spectroscopy (AAS) are standard methods employed for highly sensitive and accurate quantification of heavy metal impurities down to parts per billion (ppb) levels, ensuring that research materials meet stringent purity criteria.
Microbial Contaminants
For research applications involving cell culture, sterile solutions, or sensitive biochemical assays, the presence of microbial contaminants (bacteria, fungi, mycoplasma) in research-grade SYN-AKE poses a significant risk. Microorganisms can metabolize the peptide, produce toxins, alter cell culture media pH, compete for nutrients, or induce non-specific cellular responses (e.g., inflammation, immune activation), thereby invalidating experimental results. The risk is particularly elevated for peptides that are not terminally sterilized or that come into contact with non-sterile equipment during handling. Assessment of microbial contamination involves:
- Bioburden Testing: Enumeration of total viable aerobic microbial count and total yeast and mold count.
- Specific Pathogen Testing: Screening for objectionable microorganisms relevant to the intended research use, such as E. coli, S. aureus, and Pseudomonas aeruginosa.
- Endotoxin Testing: Limulus Amoebocyte Lysate (LAL) assay to detect bacterial endotoxins, potent pyrogens that can elicit strong cellular responses.
Strict aseptic manufacturing conditions, validated sterilization protocols for excipients and containers, and comprehensive microbial testing are essential to ensure the biological purity required for reliable cellular aging and neuromuscular signaling research. This commitment to quality is fundamental to the quality testing processes at Royal Peptide Labs.
Enantiomeric Purity and Isomeric Specificity in Research-Grade SYN-AKE Materials
The three-dimensional structure of peptides is paramount to their biological function, dictating their ability to interact with specific molecular targets like receptors or enzymes. In the realm of peptide research, particularly for a synthetic tripeptide like SYN-AKE studied in dermal neuromuscular-signaling, attention to enantiomeric purity and isomeric specificity is not merely a technical detail but a critical determinant of experimental validity and reproducibility. Amino acids, the building blocks of peptides, possess chirality, existing as L- (levo) or D- (dextro) enantiomers. Naturally occurring peptides, including those forming the basis for peptidomimetics, are almost exclusively composed of L-amino acids. Any deviation from this precise stereochemical configuration can dramatically alter the peptide’s activity, stability, and even its physiological effects in biological systems.
Enantiomeric Purity
Enantiomers are stereoisomers that are non-superimposable mirror images of each other. While chemically identical in many respects, their distinct spatial arrangements mean they can interact very differently with chiral biological environments. During peptide synthesis, particularly SPPS, racemization (the conversion of an L-amino acid to its D-form) can occur, especially during coupling reactions or under certain pH conditions. The inclusion of even minor percentages of D-amino acid impurities within a research-grade SYN-AKE sample can lead to profoundly altered biological outcomes. For example, an enantiomeric impurity might:
- Possess reduced or no biological activity, effectively diluting the active compound.
- Exhibit antagonist activity, interfering with the intended agonistic effects.
- Bind to different, unintended targets, leading to off-target effects and confounding data.
- Display altered pharmacokinetic properties, affecting cellular uptake or degradation rates in *in vitro* models.
These issues underscore the necessity for rigorous analytical methods to confirm enantiomeric purity. Chiral High-Performance Liquid Chromatography (HPLC) utilizing specialized chiral stationary phases is a primary technique, capable of separating and quantifying enantiomers. Capillary electrophoresis (CE) with chiral selectors and Nuclear Magnetic Resonance (NMR) spectroscopy with chiral shift reagents can also be employed to ensure that the SYN-AKE supplied for research is composed exclusively of the desired L-amino acid configuration, or the specified enantiomeric form if non-natural D-amino acids are intentionally incorporated.
Isomeric Specificity
Beyond enantiomeric purity, ensuring complete isomeric specificity means confirming that the synthetic peptide precisely matches the intended chemical structure, including the correct sequence of amino acids and the correct connectivity of all atoms. For a tripeptide like SYN-AKE (Dipeptide Diaminobutyroyl), while the sequence is relatively short, potential isomeric impurities could theoretically arise from mis-couplings, deletion sequences, or the formation of diastereomers if a chiral center other than the alpha-carbon is involved or if specific amino acid modifications are present. The precise assembly of the synthetic tripeptide, mimicking components studied in specific neuromuscular signaling, means that any deviation in the arrangement of its constituent parts could compromise its ability to interact with its target effectively or specifically. For instance, even slight alterations in peptide bond formation or an incorrect linking of the dipeptide unit to the diaminobutyroyl moiety could render the molecule inactive or lead to altered pharmacological profiles. Analytical techniques such as high-resolution Mass Spectrometry (MS/MS) and multi-dimensional Nuclear Magnetic Resonance (NMR) spectroscopy are instrumental in providing comprehensive structural elucidation, allowing researchers to confirm the exact sequence, connectivity, and absence of unwanted structural isomers. These detailed analyses are crucial for establishing a clear structure-activity relationship in research and for ensuring that all SYN-AKE research materials are precisely defined and consistent, facilitating reliable interpretation of its effects in cellular aging and neuromuscular research contexts.
Functional Bioassays and In Vitro Models for Research-Grade SYN-AKE Activity Verification
While stringent chemical purity assessments using techniques like HPLC, MS, and NMR are indispensable, they provide only a partial picture of a research peptide’s quality. For a bioactive peptide like SYN-AKE, a synthetic tripeptide studied in dermal neuromuscular-signaling research, confirming its functional activity in relevant biological systems is paramount. Chemical purity alone does not guarantee biological potency or specificity. Functional bioassays and *in vitro* models are essential for verifying that the research-grade SYN-AKE not only possesses the correct chemical structure but also elicits the anticipated biological response, consistent with its proposed mechanism of action in modulating muscle contraction pathways. This verification is critical for ensuring the reliability and interpretability of subsequent mechanistic research in cellular aging and related fields, such as those exploring neuromuscular function.
SYN-AKE Mechanism of Action and Bioassay Design
SYN-AKE is known to be a peptidomimetic of Waglerin 1, a peptide found in Temple Viper venom. Its proposed mechanism involves reversibly inhibiting muscle nicotinic acetylcholine receptors (nAChR) at the postsynaptic membrane, thereby modulating neuromuscular signaling and muscle contraction. Understanding this specific mechanism is foundational for designing appropriate functional assays. Verification should thus focus on its ability to influence muscle cell activity. Researchers interested in the detailed mechanism can explore the dedicated resource on SYN-AKE mechanism of action.
Cellular Bioassays for Activity Verification
Several *in vitro* models can be employed to assess the functional activity of research-grade SYN-AKE:
- Neuromuscular Junction (NMJ) Models: Co-culture systems involving motor neurons and muscle cells (e.g., C2C12 myotubes, primary muscle cells, or iPSC-derived neurons and myotubes) can be established. SYN-AKE’s ability to modulate acetylcholine-induced muscle contraction or inhibit spontaneous muscle twitching can be directly observed and quantified using video microscopy or electromyography (EMG) techniques.
- Isolated Muscle Fiber Contraction Assays: Using isolated muscle fibers or strips, the direct effect of SYN-AKE on muscle contractility can be measured with force transducers. This allows for dose-response curves to be generated, determining the IC50 (half maximal inhibitory concentration) or EC50 (half maximal effective concentration) of the peptide.
- Nicotinic Acetylcholine Receptor (nAChR) Functional Assays: As SYN-AKE targets nAChR, cell lines expressing these receptors (e.g., human embryonic kidney (HEK293) cells transfected with nAChR subunits) can be used. Calcium imaging techniques can assess the peptide’s ability to inhibit agonist-induced calcium influx, a direct measure of nAChR activity. Alternatively, patch-clamp electrophysiology can directly measure ion channel currents.
- Cell Viability and Cytotoxicity Assays: While primarily focused on activity, it’s also important to confirm that the observed effects are not due to non-specific cytotoxicity. Assays like MTT, AlamarBlue, or LDH release can be performed on muscle cells or neurons treated with SYN-AKE to ensure its effects are pharmacologically specific rather than toxicological.
Biochemical and Molecular Assays
Beyond direct cellular responses, more granular biochemical and molecular assays can corroborate SYN-AKE’s activity:
- Receptor Binding Assays: If a specific nAChR subtype is identified as the primary target, competitive radioligand or fluorescence-based binding assays can quantify SYN-AKE’s affinity for the receptor.
- Signaling Pathway Analysis: Techniques such as Western blotting, ELISA, or quantitative PCR can be used to assess downstream signaling events related to nAChR inhibition or muscle contraction pathways. For instance, changes in phosphorylation states of key proteins involved in muscle contraction or gene expression changes related to muscle function can be monitored.
The inclusion of appropriate controls—vehicle, positive control (e.g., known nAChR antagonist), and a reference standard of SYN-AKE with known activity—is crucial for validating these functional assays and ensuring that the observed effects are specific, dose-dependent, and reproducible across different research batches. This comprehensive approach to activity verification ensures that researchers have high-confidence materials for their investigations into cellular aging and neuromuscular mechanisms.
Stability Profile, Degradation Pathways, and Storage Considerations for Research-Grade SYN-AKE
The integrity of research-grade SYN-AKE, a synthetic tripeptide studied in dermal neuromuscular-signaling research, is paramount for the reproducibility and validity of experimental results. Understanding its stability profile, potential degradation pathways, and optimal storage conditions is a critical aspect of quality control in cellular aging research. Peptides, by their very nature, are susceptible to various chemical and physical degradation processes that can alter their structure, purity, and ultimately, their biological activity. These degradation events can introduce impurities, modify the active peptide, or even lead to the formation of entirely new, potentially confounding, compounds within a research sample.
Key degradation pathways for peptides like SYN-AKE typically include hydrolysis, oxidation, racemization, and aggregation. Hydrolysis, particularly of the amide bonds within the peptide backbone, can occur in the presence of water, especially under acidic or basic conditions, leading to cleavage and the formation of smaller peptide fragments or individual amino acids. Oxidation can affect specific amino acid residues, such as methionine, cysteine, tryptophan, and tyrosine, potentially altering the peptide’s conformation and biological function. Racemization, the conversion of a chiral L-amino acid to its D-enantiomer, can occur over time and may significantly impact the peptide’s interaction with specific biological targets. Aggregation, a physical degradation process, can result in the formation of insoluble or less soluble aggregates, reducing the effective concentration of the active peptide in solution and potentially interfering with experimental assays. Factors such as temperature, light exposure, pH of the solution, and the presence of metal ions or oxidizing agents can accelerate these degradation processes.
Optimal Storage Conditions for SYN-AKE
To mitigate degradation and maintain the high purity and activity of research-grade SYN-AKE, stringent storage protocols are essential. The precise conditions may vary slightly depending on the specific formulation (e.g., lyophilized powder vs. solution), but general guidelines are widely adopted across peptide research. Lyophilized SYN-AKE is typically more stable and should be stored in a tightly sealed container, protected from light, at very low temperatures (e.g., -20°C or -80°C). Desiccants can be employed to minimize moisture exposure, as residual moisture can accelerate hydrolysis. For solutions, storage conditions become even more critical. Peptide solutions should generally be prepared immediately before use or stored in small aliquots to minimize freeze-thaw cycles, which can induce aggregation or degradation. Buffers used for reconstitution should be selected carefully to maintain an optimal pH range for peptide stability, often slightly acidic to neutral. Furthermore, protection from light is crucial to prevent photodegradation, and the use of inert gas (e.g., argon or nitrogen) during storage can help minimize oxidative processes. For detailed, lot-specific storage and handling recommendations, researchers should always consult the Certificate of Analysis (CoA) and any accompanying documentation provided by the supplier. Additional insights into proper handling can be found on our SYN-AKE Storage and Handling page.
Establishing Reference Standards and Robust Quality Control Protocols for SYN-AKE Research
For research involving synthetic peptides like SYN-AKE, establishing robust quality control (QC) protocols and utilizing well-characterized reference standards are foundational to generating reliable and reproducible data. Reference standards serve as benchmarks against which the purity, identity, and potency of research-grade materials are evaluated. They provide a common point of comparison across different batches, experiments, and even different laboratories, thereby reducing inter-study variability that could otherwise confound research findings on dermal neuromuscular-signaling mechanisms.
Types and Purpose of Reference Standards
Reference standards for SYN-AKE can be categorized into primary and secondary standards. A **primary reference standard** is typically a highly purified and extensively characterized batch of SYN-AKE, whose identity, purity, and concentration are established through a battery of analytical techniques to the highest possible degree of accuracy. This standard serves as the ultimate benchmark for all subsequent testing. A **secondary reference standard** is a working standard that is routinely used for QC testing and is calibrated against the primary reference standard. The primary purpose of these standards is multifaceted:
- Method Validation: Used to validate analytical methods (e.g., HPLC, MS) by confirming specificity, accuracy, precision, linearity, and limits of detection/quantitation.
- Quantitative Analysis: Essential for accurate quantification of SYN-AKE in research samples, allowing for precise dosing in in vitro or ex vivo models.
- Purity Assessment: Enables the comparison of a test sample’s purity profile against a known, high-purity standard, identifying potential impurities or degradation products.
- Identity Confirmation: Helps confirm the chemical identity of SYN-AKE batches through spectroscopic or chromatographic comparison.
- Batch-to-Batch Consistency: Ensures that different lots of research material perform consistently, which is crucial for long-term studies and multi-batch experiments.
Robust Quality Control Protocols
Robust QC protocols encompass a comprehensive series of analytical tests applied at various stages of the peptide synthesis and purification process, culminating in final product assessment. These protocols are designed to confirm that each batch of research-grade SYN-AKE meets predefined specifications for purity, identity, and the absence of deleterious contaminants. The suite of analytical techniques employed often includes:
| Analytical Technique | Primary Application in SYN-AKE QC |
|---|---|
| High-Performance Liquid Chromatography (HPLC) | Purity assessment, quantification, detection of related substances (impurities, degradation products). |
| Mass Spectrometry (MS) | Confirmation of molecular weight and chemical identity, sequencing of fragments to verify structure. |
| Nuclear Magnetic Resonance (NMR) Spectroscopy | Detailed structural elucidation, confirmation of chemical shifts, identification of isomers and impurities. |
| Fourier-Transform Infrared (FTIR) Spectroscopy | Confirmation of functional groups and overall molecular fingerprint. |
| Elemental Analysis | Determination of empirical formula, detection of inorganic impurities. |
| Residual Solvent Analysis | Ensuring absence of synthesis solvents (e.g., by Gas Chromatography). |
| Heavy Metal Testing | Detection of trace metal contaminants (e.g., by ICP-MS). |
| Microbial Contamination Testing | Ensuring suitability for cellular and tissue culture applications. |
By integrating these rigorous analytical methods with the use of well-characterized reference standards, research laboratories can ensure the integrity of their SYN-AKE materials, thereby enhancing the reliability and reproducibility of their cellular aging research. Our commitment to these standards is detailed further on our Quality Testing page.
Supplier Qualification and Certificate of Analysis (CoA) Verification for Research-Use SYN-AKE
The success and credibility of cellular aging research utilizing synthetic peptides like SYN-AKE are profoundly influenced by the quality of the raw materials. Therefore, the rigorous qualification of suppliers and meticulous verification of their Certificates of Analysis (CoAs) are indispensable steps in the procurement process for research-grade SYN-AKE. A reliable supplier acts as an extension of a research laboratory’s own quality control, providing assurance that the materials meet the specified research requirements and are consistent from batch to batch. Without a robust supplier qualification process, researchers risk introducing variability or confounding factors into their experiments, which can lead to erroneous conclusions or irreproducible results.
Criteria for Supplier Qualification
When selecting a supplier for research-grade SYN-AKE, several critical factors should be considered beyond mere price. These criteria collectively assess the supplier’s capability to consistently provide high-quality, well-characterized materials:
- Manufacturing Standards: Evaluate the supplier’s adherence to quality manufacturing practices, even if not strictly pharmaceutical-grade GMP, to ensure controlled processes and minimize contamination.
- Analytical Capabilities: Assess the depth and breadth of their in-house analytical testing (e.g., HPLC, MS, NMR, FTIR, elemental analysis, residual solvent analysis, heavy metal screening, microbial testing).
- Transparency and Documentation: Demand clear, comprehensive, and accessible documentation, including method validation data, stability data, and detailed CoAs for every lot.
- Track Record and Reputation: Research the supplier’s history, customer reviews, and any public quality control issues.
- Consistency: Inquire about their batch-to-batch consistency and how they manage variations.
- Responsiveness and Support: A reliable supplier should offer prompt and knowledgeable technical support.
Certificate of Analysis (CoA) Verification
The Certificate of Analysis (CoA) is a critical document provided by the supplier that details the results of specific quality tests performed on a particular lot of SYN-AKE. It serves as a declaration of the product’s quality and conformance to specifications. However, simply receiving a CoA is not sufficient; researchers must meticulously verify its contents to ensure the material is appropriate for their intended research applications. Our Certificate of Analysis (CoA) page provides further insights into the significance of this document.
When verifying a SYN-AKE CoA, researchers should look for the following essential information:
- Product Identification: Clear naming (e.g., SYN-AKE, Dipeptide Diaminobutyroyl), lot number, and date of manufacture.
- Purity Assessment: Detailed results from primary purity assays, typically HPLC, showing the percentage of the main component and identifying any known impurities.
- Identity Confirmation: Data from techniques like Mass Spectrometry (MS) confirming the molecular weight and often a fragment analysis, and potentially NMR or FTIR data.
- Residual Solvents: Confirmation that residual solvents used in synthesis are below acceptable limits.
- Heavy Metals: Results of screening for common heavy metal contaminants.
- Water Content: Often determined by Karl Fischer titration, important for accurate weighing and stability.
- Microbial Load: For materials intended for cell culture, data on bacterial and fungal contamination.
- Storage Recommendations and Re-test Date/Expiry: Crucial for maintaining material integrity over time.
- Analytical Methods: Specific methods used for each test (e.g., HPLC conditions, MS parameters) should be referenced.
Beyond reviewing the data on the CoA, researchers should compare it against their own internal specifications or expected values. Any discrepancies or omissions warrant further investigation with the supplier. In some cases, independent third-party testing may be advisable to confirm critical parameters, especially for highly sensitive research applications. This diligent approach to supplier qualification and CoA verification forms a crucial safeguard against the use of substandard materials, protecting the integrity and reproducibility of cellular aging research.
Implications of SYN-AKE Purity on Mechanistic Research and Reproducibility in Cellular Aging Studies
In the intricate landscape of cellular aging research, the integrity and purity of investigational compounds like SYN-AKE are not merely desirable attributes but fundamental prerequisites for obtaining valid and reproducible scientific outcomes. SYN-AKE, a synthetic tripeptide studied extensively in dermal neuromuscular-signaling research, offers a compelling model for understanding the profound impact of material quality on experimental rigor. As researchers delve into the complex mechanisms underlying cellular senescence, proteostasis, mitochondrial dysfunction, and other hallmarks of aging, even trace impurities in a compound can subtly or dramatically alter cellular responses, leading to misinterpretations of data and ultimately hindering scientific progress.
The unique mechanism of SYN-AKE, involving modulation of neuromuscular signaling, suggests that its biological activity is highly sensitive to its precise chemical structure. Any deviation from this structure, whether through incomplete synthesis, side-product formation, or degradation, has the potential to introduce off-target effects or diminish the intended activity. In cellular aging models, where subtle shifts in cellular homeostasis can have profound long-term consequences, such structural impurities present a significant challenge. Robust purity assessment, encompassing a suite of analytical techniques from High-Performance Liquid Chromatography (HPLC) to Nuclear Magnetic Resonance (NMR) and Mass Spectrometry (MS), is therefore not just a quality control measure, but an essential component of experimental design that directly underpins the reliability of mechanistic investigations into SYN-AKE’s role in aging pathways.
Confounding Factors in Mechanistic Research Due to Impurities
The presence of impurities in research-grade SYN-AKE can introduce a myriad of confounding factors that obscure or distort the true mechanistic insights sought in cellular aging studies. These impurities can arise from various stages, including synthesis, purification, handling, and storage. For a tripeptide like SYN-AKE, which is designed to interact with specific biological targets, even minor chemical variants or co-purified contaminants can compete for binding sites, elicit alternative signaling cascades, or alter cellular permeability and metabolism. This can lead to false positive results, where an observed effect is attributed to SYN-AKE when, in reality, it is caused by an impurity. Conversely, impurities might also mask a genuine effect of SYN-AKE, leading to false negative conclusions or underestimation of its potency.
Consider the potential for off-target interactions: a structurally similar impurity might partially mimic SYN-AKE’s activity but with different kinetics or efficacy, leading to complex, non-linear dose-response curves that are difficult to interpret. Alternatively, an unrelated impurity could exert its own cytotoxic or stimulatory effects, independent of SYN-AKE, thereby confounding the observed cellular phenotype. For instance, residual solvents or heavy metals, often present even in high-purity materials if not rigorously controlled, can induce oxidative stress, alter enzyme activity, or trigger inflammatory responses, all of which are pertinent to cellular aging processes. These artifactual effects can severely compromise the validity of data on markers such as senescence-associated β-galactosidase activity, mitochondrial membrane potential, or levels of reactive oxygen species, making it nearly impossible to attribute changes specifically to SYN-AKE.
Moreover, the concentration and nature of impurities can vary significantly between different batches or suppliers of SYN-AKE. Such variability directly impacts experimental consistency, making it challenging to establish robust mechanistic relationships. Researchers aiming to elucidate how SYN-AKE influences specific cellular aging pathways, such as those governing protein aggregation, DNA repair, or telomere dynamics, require a compound with a highly defined and consistent chemical profile. Without this, observed modulations in these pathways could be attributed to a cocktail of active substances rather than the intended tripeptide, rendering conclusions unreliable and potentially misleading the research community.
Impact on Reproducibility and Comparability Across Studies
Perhaps one of the most detrimental consequences of impure research materials is their profound impact on the reproducibility and comparability of scientific findings. The lack of reproducibility has become a significant concern across various scientific disciplines, and the quality of reagents, including specialized peptides like SYN-AKE, is a primary contributing factor. When different research groups, or even the same group at different times, use SYN-AKE preparations with varying impurity profiles, discrepancies in experimental outcomes are almost inevitable. These variations undermine the foundation of cumulative science, where findings are expected to be verifiable and build upon one another.
For SYN-AKE, a synthetic tripeptide that has already been the subject of numerous PubMed publications and several ClinicalTrials.gov registered studies, ensuring batch-to-batch consistency and a high standard of purity is paramount for confirming and extending existing knowledge. If a study reports a specific effect of SYN-AKE on a cellular aging marker, and a subsequent study fails to replicate this finding using a different batch of seemingly the same compound, the scientific community faces ambiguity. Was the original finding an artifact of an impurity? Was the second batch less pure, or did it contain different active contaminants? Resolving such questions consumes valuable research resources and time.
To illustrate the diverse ways impurities can derail reproducibility, consider the following categories:
| Purity Aspect | Potential Consequence for Reproducibility |
|---|---|
| Chemical Impurities (e.g., synthesis byproducts, incomplete cleavage products, truncated peptides) | Variable off-target effects; inconsistent primary mechanism modulation; altered cellular uptake or stability; competition for target binding. |
| Residual Solvents (e.g., trifluoroacetic acid, dimethylformamide) | Direct cytotoxicity or signaling interference; alterations in solubility and formulation behavior; interference with cellular enzymatic processes. |
| Heavy Metals (e.g., lead, cadmium, mercury) | General cellular toxicity; induction of oxidative stress; interference with protein folding and enzymatic activity; genotoxic effects. |
| Microbial Contaminants (e.g., bacteria, fungi, and their endotoxins) | Activation of innate immune responses; inflammatory signaling artifacts; cell culture stress; changes in nutrient availability and pH. |
| Degradation Products (e.g., from improper storage, light exposure, or intrinsic instability) | Loss of primary compound activity; accumulation of potentially active, inactive, or toxic breakdown products; reduced shelf life and inconsistent potency over time. |
Each of these categories represents a variable that can introduce noise into experimental data, making it difficult to establish clear cause-and-effect relationships and reproduce findings across laboratories or even different experimental runs. This underscores the critical need for comprehensive analytical testing and transparent reporting of purity data, ensuring that the research community can rely on the consistency and fidelity of materials like SYN-AKE. Researchers should always scrutinize the Certificate of Analysis (CoA) provided by their supplier to understand the full chemical profile of the SYN-AKE they are utilizing.
Specific Challenges in Cellular Aging Research
Cellular aging research presents a particularly sensitive context for the purity of research compounds. Studies in this field often involve long-duration experiments, where cells are exposed to compounds for extended periods to observe subtle, progressive changes characteristic of aging. Over these prolonged exposures, even trace impurities or their degradation products can accumulate to biologically significant levels, inducing chronic stress, altering metabolism, or activating extraneous signaling pathways that confound the results. For example, if a SYN-AKE preparation contains an impurity that causes mild, persistent oxidative stress, any observed effects on cellular senescence or antioxidant defense mechanisms might be erroneously attributed to SYN-AKE itself, rather than the contaminant.
Moreover, the endpoints in cellular aging research are often complex and multifactorial, involving an intricate interplay of molecular pathways. Investigations into SYN-AKE’s potential influence on critical aging hallmarks, such as mitochondrial function, autophagy, epigenetics, or telomere maintenance, demand exquisitely pure materials. Impurities can interfere with sensitive assays designed to measure these endpoints. For instance, heavy metal contaminants can directly impair mitochondrial respiration, while microbial endotoxins can trigger inflammatory cascades that mimic or mask age-related inflammatory responses. The very nature of cellular aging research, which often seeks to identify subtle modulators of complex biological processes, amplifies the need for unparalleled purity.
To confidently explore SYN-AKE’s specific mechanistic contributions to cellular aging, researchers must be assured that any observed effects are unequivocally attributable to the tripeptide itself. This necessitates a profound commitment to quality control throughout the entire supply chain, from synthesis to storage. Royal Peptide Labs employs a rigorous quality testing regimen designed to mitigate these risks, ensuring that researchers can trust the purity and identity of the SYN-AKE they receive. Without such stringent measures, the extensive efforts invested in cellular aging research, including the numerous studies already published and registered for SYN-AKE, risk generating irreproducible data and obscuring true biological insights into this fascinating synthetic tripeptide.
Frequently Asked Questions
What is SYN-AKE, and what is its primary focus in research contexts?
SYN-AKE is a synthetic tripeptide, also known by the alias Dipeptide Diaminobutyroyl. Its mechanism of action involves modulation of dermal neuromuscular signaling, making it a subject of study in various in vitro and in vivo research models exploring these pathways.
Q: What purity specifications can researchers expect for SYN-AKE from Royal Peptide Labs?
A: Royal Peptide Labs provides SYN-AKE intended for research applications with a defined purity profile. Each batch undergoes rigorous analysis, typically verified by High-Performance Liquid Chromatography (HPLC), to ensure it meets our stringent internal standards for research-grade materials.
Q: How does Royal Peptide Labs verify the identity and purity of SYN-AKE?
A: The identity of SYN-AKE is confirmed through analytical techniques such as Mass Spectrometry (MS). Purity is primarily assessed via High-Performance Liquid Chromatography (HPLC) to quantify the main peptide component and detect potential impurities. These tests are critical for ensuring the suitability of the compound for sensitive research experiments.
Q: Are Certificates of Analysis (CoAs) provided with SYN-AKE orders?
A: Yes, a comprehensive Certificate of Analysis (CoA) is available with every order of research-grade SYN-AKE. The CoA details key analytical data, including purity by HPLC, molecular weight, and any other relevant specifications to assist researchers in their experimental design and data interpretation.
Q: What are the recommended storage conditions for SYN-AKE to preserve its integrity for research studies?
A: To maintain the stability and purity of SYN-AKE for prolonged research use, it is generally recommended to store the compound in a cool, dry environment, protected from light. Specific instructions, including recommended temperature ranges, are provided on the product label and CoA to optimize storage for research applications.
Q: How does Royal Peptide Labs ensure batch-to-batch consistency for SYN-AKE?
A: Royal Peptide Labs implements a strict quality control protocol to ensure high batch-to-batch consistency for all research compounds, including SYN-AKE. This involves comprehensive analytical testing of each production batch, comparing results against established specifications to confirm uniformity for reliable experimental replication.
Q: Are there any alternative names or synonyms for SYN-AKE that researchers should be aware of?
A: Yes, researchers may encounter SYN-AKE referred to by its alias, Dipeptide Diaminobutyroyl. Being aware of these alternative names can be beneficial when conducting literature reviews or searching databases for related research.
Q: Where can researchers find existing literature or study information on SYN-AKE?
A: Researchers can find numerous indexed publications concerning SYN-AKE (Dipeptide Diaminobutyroyl) in scientific databases like PubMed. Additionally, several registered studies involving this compound can be found on platforms such as ClinicalTrials.gov, providing further context for ongoing research.
Scientific References
All information from Royal Peptide Labs is provided for in-vitro laboratory and research use only — not for human, veterinary, diagnostic, or therapeutic use.